← All companies

OTLC

Oncotelic Therapeutics, Inc.

OTLC OTC Pharmaceutical Preparations EDGAR ↗

$0.04

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$17.8M

Revenue (TTM)

$70.0K

Net income (TTM)

$247M

EPS (TTM)

$0.59

P/E ratio

0.1

Dividend yield

—

Free cash flow

-$1.40M

Cash

$409K

Total assets

$394M

Gross margin

—

52-week range

$0.02 – $0.11

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Other events Jul 14, 2026 8-K Unregistered sale of equity; Director or officer change Jul 14, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jun 29, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity May 5, 2026 8-K Other events Apr 16, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Entered a material agreement; Other events Apr 2, 2026 8-K Other events Mar 30, 2026 8-K Other events Mar 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jan 29, 2026 8-K Entered a material agreement; Director or officer change Jan 26, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Jan 7, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jan 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Jan 6, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 30, 2025 8-K Other events Dec 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 17, 2025 8-K Other events Oct 22, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 12, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 6, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Other events Mar 25, 2025 8-K Other events Jan 2, 2025 10-Q Quarter ended 2024-09-30 Nov 19, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Other events Apr 29, 2024 10-K Fiscal year ended 2023-12-31 Apr 12, 2024 8-K Entered a material agreement; Unregistered sale of equity Feb 2, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Entered a material agreement; Unregistered sale of equity Oct 30, 2023 8-K Regulation FD disclosure Aug 23, 2023 10-Q Quarter ended 2023-06-30 Aug 18, 2023 8-K Entered a material agreement; Unregistered sale of equity Jul 13, 2023 10-Q Quarter ended 2023-03-31 May 22, 2023 8-K Amended charter or bylaws May 19, 2023